Clinical Trials Browser

Phase 1/2 × OTHER × fosaprepitant × Clear all

NCT02780609 2022-11-04

Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma

Phase 1/2 Completed

22 enrolled 16 charts

Multiple Myeloma

NCT01031953 2017-05-09

Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy

Phase 1/2 Terminated

34 enrolled 12 charts

Nausea, Vomiting